By Giulia Petroni 
 

Bayer AG said Tuesday that it appointed Christian Rommel as the new head of research and development at its pharmaceuticals division, effective from Feb. 1.

The German pharmaceutical and chemical conglomerate said Mr. Rommel will succeed Joerg Moeller, who decided to leave the company effective Dec. 31 to pursue other career opportunities.

Mr. Rommel will serve on the pharmaceuticals executive committee and report to Stefan Oelrich, the division's president and a member of the board of management.

Prior to joining Bayer, Mr. Rommel served as senior vice president and global head of oncology research and early development at Hoffmann-La Roche AG.

 

Write to Giulia Petroni at giulia.petroni@wsj.com

 

(END) Dow Jones Newswires

October 27, 2020 09:31 ET (13:31 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Oct 2020 to Nov 2020 Click Here for more Bayer Aktiengesellschaft (PK) Charts.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Nov 2019 to Nov 2020 Click Here for more Bayer Aktiengesellschaft (PK) Charts.